Man Group’s Meridian Bioscience Inc VIVO Stock Holding History

Man Group’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Hold	0	–	–	–	1321
2021 Q3	–	Sell	-10,400	Closed	-$231K	–	2169
2021 Q2	$231K	Buy	+10,400	New	+$221K	﹤0.01%	1764
2020 Q2	–	Sell	-13,621	Closed	-$114K	–	1867
2020 Q1	$114K	Sell	13,621 -181,442	-93%	-$1.53M	﹤0.01%	1509
2019 Q4	$1.91M	Sell	195,063 -4,552	-2%	-$42.7K	0.01%	1341
2019 Q3	$1.89M	Sell	199,615 -6,121	-3%	-$64.5K	0.01%	1264
2019 Q2	$2.44M	Sell	205,736 -20,166	-9%	-$243K	0.01%	1241
2019 Q1	$3.98M	Buy	225,902 +14,764	+7%	+$246K	0.02%	1039
2018 Q4	$3.67M	Sell	211,138 -75,333	-26%	-$1.28M	0.02%	928
2018 Q3	$4.27M	Buy	286,471 +4,516	+2%	+$70K	0.02%	1085
2018 Q2	$4.48M	Buy	281,955 +31,830	+13%	+$475K	0.02%	1004
2018 Q1	$3.55M	Buy	+250,125	New	+$3.7M	0.02%	1036

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VLKIM

Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return

Man Group's VIVO Position: Q2 2022 in Review

Man Group held its Meridian Bioscience Inc (VIVO) position steady in Q2 2022 at 0 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Man Group first reported a position in VIVO in Q1 2018 and has held it in 10 quarters since. The position peaked at $4.48M in Q2 2018. 216 funds tracked by Wall St. Rank hold VIVO as of Q2 2022.

Man Group held 0 shares of Meridian Bioscience Inc worth $1.05M as of Q2 2022.
Man Group left its Meridian Bioscience Inc share count unchanged in Q2 2022.
Meridian Bioscience Inc made up ﹤0.01% of Man Group's portfolio in Q2 2022, its #1321 holding.
Man Group first reported a position in Meridian Bioscience Inc in Q1 2018 and has held it in 10 quarters since.
Man Group's Meridian Bioscience Inc position peaked at $4.48M in Q2 2018.
216 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2022.

Based on Man Group's 13F filing for Q2 2022, filed 15 Aug 2022.